Pinnacle Wealth Management Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $679K | Sell |
1,294
-234
| -15% | -$123K | 0.06% | 183 |
|
|
2025
Q1 | $969K | Buy |
1,528
+487
| +47% | +$309K | 0.09% | 140 |
|
|
2024
Q4 | $742K | Sell |
1,041
-221
| -18% | -$157K | 0.07% | 160 |
|
|
2024
Q3 | $1.33M | Buy |
1,262
+123
| +11% | +$129K | 0.13% | 113 |
|
|
2024
Q2 | $1.2M | Buy |
1,139
+376
| +49% | +$395K | 0.12% | 120 |
|
|
2024
Q1 | $734K | Buy |
763
+63
| +9% | +$60.6K | 0.08% | 152 |
|
|
2023
Q4 | $615K | Hold |
700
| – | – | 0.07% | 158 |
|
|
2023
Q3 | $576K | Buy |
700
+4
| +0.6% | +$3.29K | 0.07% | 162 |
|
|
2023
Q2 | $500K | Sell |
696
-50
| -7% | -$35.9K | 0.06% | 182 |
|
|
2023
Q1 | $613K | Buy |
746
+88
| +13% | +$72.3K | 0.08% | 159 |
|
|
2022
Q4 | $475K | Buy |
658
+77
| +13% | +$55.6K | 0.07% | 175 |
|
|
2022
Q3 | $400K | Buy |
581
+152
| +35% | +$105K | 0.07% | 180 |
|
|
2022
Q2 | $254K | Buy |
+429
| New | +$254K | 0.04% | 248 |
|